on June 12, 2003
Published online before print June 12, 2003, doi: 10.1161/01.STR.0000078311.18928.16
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on February 6, 2003
From the Division of General Internal Medicine and the Center for Clinical Effectiveness, University of Cincinnati, Cincinnati, Ohio (M.H.E.), and Departments of Neurology (J.R., K.A.K., S.M.G.) and Medicine (D.E.S.), Massachusetts General Hospital, Boston. * To whom correspondence should be addressed. E-mail: mark.eckman{at}uc.edu.
Background and Purpose--Warfarin increases both the likelihood and the mortality of intracerebral hemorrhage (ICH), particularly in patients with a history of prior ICH. In light of this consideration, should a patient with both a history of ICH and a clear indication for anticoagulation such as nonvalvular atrial fibrillation be anticoagulated? In the absence of data from a clinical trial, we used a decision-analysis model to compare the expected values of 2 treatment strategies--warfarin and no anticoagulation--for such patients. Methods--We used a Markov state transition decision model stratified by location of hemorrhage (lobar or deep hemispheric). Effectiveness was measured in quality-adjusted life years (QALYs). Data sources included English language literature identified through MEDLINE searches and bibliographies from selected articles, along with empirical data from our own institution. The base case focused on a 69-year-old man with a history of ICH and newly diagnosed nonvalvular atrial fibrillation. Results--For patients with prior lobar ICH, withholding anticoagulation therapy was strongly preferred, improving quality-adjusted life expectancy by 1.9 QALYs. For patients with prior deep hemispheric ICH, withholding anticoagulation resulted in a smaller gain of 0.3 QALYs. In sensitivity analyses for patients with deep ICH, anticoagulation could be preferred if the risk of thromboembolic stroke is particularly high. Conclusions--Survivors of lobar ICH with atrial fibrillation should not be offered long-term anticoagulation. Similarly, most patients with deep hemispheric ICH and atrial fibrillation should not receive anticoagulant therapy. However, patients with deep hemispheric ICH at particularly high risk for thromboembolic stroke or low risk of ICH recurrence might benefit from long-term anticoagulation.
Accepted on February 25, 2003
Can Patients Be Anticoagulated After Intracerebral Hemorrhage? A Decision Analysis
Mark H. Eckman MD*;
Key words: atrial fibrillation • decision support techniques • intracerebral hemorrhage • Markov chains • warfarin
This article has been cited by other articles:
 |
|
 |
|
  C. E. Lovelock, P. Anslow, A. J. Molyneux, J. V. Byrne, W. Kuker, P. M. Pretorius, A. Coull, and P. M. Rothwell Substantial Observer Variability in the Differentiation Between Primary Intracerebral Hemorrhage and Hemorrhagic Transformation of Infarction on CT Brain Imaging Stroke, December 1, 2009; 40(12): 3763 - 3767. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R.N.K. Nandigam, A. Viswanathan, P. Delgado, M.E. Skehan, E.E. Smith, J. Rosand, S.M. Greenberg, and B.C. Dickerson MR Imaging Detection of Cerebral Microbleeds: Effect of Susceptibility-Weighted Imaging, Section Thickness, and Field Strength AJNR Am. J. Neuroradiol., February 1, 2009; 30(2): 338 - 343. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. H. Eckman, L. K.S. Wong, Y. O.Y. Soo, W. Lam, S. R. Yang, S. M. Greenberg, and J. Rosand Patient-Specific Decision-Making for Warfarin Therapy in Nonvalvular Atrial Fibrillation: How Will Screening With Genetics and Imaging Help? * Supplemental Appendix Stroke, December 1, 2008; 39(12): 3308 - 3315. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. O. Claassen, N. Kazemi, A. Y. Zubkov, E. F. M. Wijdicks, and A. A. Rabinstein Restarting Anticoagulation Therapy After Warfarin-Associated Intracerebral Hemorrhage Arch Neurol, October 1, 2008; 65(10): 1313 - 1318. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Y. Zubkov, J. N. Mandrekar, D. O. Claassen, E. M. Manno, E. F. M. Wijdicks, and A. A. Rabinstein Predictors of Outcome in Warfarin-Related Intracerebral Hemorrhage Arch Neurol, October 1, 2008; 65(10): 1320 - 1325. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Ueno, H. Naka, T. Ohshita, K. Kondo, E. Nomura, T. Ohtsuki, T. Kohriyama, S. Wakabayashi, and M. Matsumoto Association between Cerebral Microbleeds on T2*-Weighted MR Images and Recurrent Hemorrhagic Stroke in Patients Treated with Warfarin following Ischemic Stroke AJNR Am. J. Neuroradiol., September 1, 2008; 29(8): 1483 - 1486. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Broderick, S. Connolly, E. Feldmann, D. Hanley, C. Kase, D. Krieger, M. Mayberg, L. Morgenstern, C. S. Ogilvy, P. Vespa, et al. REPRINT: Guidelines for the Management of Spontaneous Intracerebral Hemorrhage in Adults: 2007 Update: A Guideline From the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Circulation, October 16, 2007; 116(16): e391 - e413. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H C Hanger, T J Wilkinson, N Fayez-Iskander, and R Sainsbury The risk of recurrent stroke after intracerebral haemorrhage J. Neurol. Neurosurg. Psychiatry, August 1, 2007; 78(8): 836 - 840. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Benbassat and R. Baumal The time horizons of formal decision analyses QJM, June 1, 2007; 100(6): 383 - 388. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Broderick, S. Connolly, E. Feldmann, D. Hanley, C. Kase, D. Krieger, M. Mayberg, L. Morgenstern, C. S. Ogilvy, P. Vespa, et al. Guidelines for the Management of Spontaneous Intracerebral Hemorrhage in Adults: 2007 Update: A Guideline From the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke, June 1, 2007; 38(6): 2001 - 2023. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. I. Aguilar, R. G. Hart, C. S. Kase, W. D. Freeman, B. J. Hoeben, R. C. Garcia, J. E. Ansell, S. A. Mayer, B. Norrving, J. Rosand, et al. Treatment of Warfarin-Associated Intracerebral Hemorrhage: Literature Review and Expert Opinion Mayo Clin. Proc., January 1, 2007; 82(1): 82 - 92. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Thanvi and T. Robinson Sporadic cerebral amyloid angiopathy--an important cause of cerebral haemorrhage in older people Age Ageing, November 1, 2006; 35(6): 565 - 571. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. R. Earnshaw, A. V. Joshi, M. R. Wilson, and J. Rosand Cost-Effectiveness of Recombinant Activated Factor VII in the Treatment of Intracerebral Hemorrhage Stroke, November 1, 2006; 37(11): 2751 - 2758. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. L. Sacco, R. Adams, G. Albers, M. J. Alberts, O. Benavente, K. Furie, L. B. Goldstein, P. Gorelick, J. Halperin, R. Harbaugh, et al. Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association Council on Stroke: Co-Sponsored by the Council on Cardiovascular Radiology and Intervention: The American Academy of Neurology affirms the value of this guideline. Circulation, March 14, 2006; 113(10): e409 - e449. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. L. Sacco, R. Adams, G. Albers, M. J. Alberts, O. Benavente, K. Furie, L. B. Goldstein, P. Gorelick, J. Halperin, R. Harbaugh, et al. Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association Council on Stroke: Co-Sponsored by the Council on Cardiovascular Radiology and Intervention: The American Academy of Neurology affirms the value of this guideline. Stroke, February 1, 2006; 37(2): 577 - 617. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Viswanathan and H. Chabriat Cerebral Microhemorrhage Stroke, February 1, 2006; 37(2): 550 - 555. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. B. Goldstein Primum non nocere: Antithombotics after intracerebral hemorrhage? Neurology, January 24, 2006; 66(2): 162 - 163. [Full Text] [PDF]
|
|
|
|
|
|
A. Viswanathan, S. M. Rakich, C. Engel, R. Snider, J. Rosand, S. M. Greenberg, and E. E. Smith Antiplatelet use after intracerebral hemorrhage Neurology, January 24, 2006; 66(2): 206 - 209. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Steiner, J. Rosand, and M. Diringer Intracerebral Hemorrhage Associated With Oral Anticoagulant Therapy: Current Practices and Unresolved Questions Stroke, January 1, 2006; 37(1): 256 - 262. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Wani, E. Nga, and R. Navaratnasingham Should a patient with primary intracerebral haemorrhage receive antiplatelet or anticoagulant therapy? BMJ, August 20, 2005; 331(7514): 439 - 442. [Full Text] [PDF]
|
|
|
|
|
|
E. M. Manno, J. L. D. Atkinson, J. R. Fulgham, and E. F. M. Wijdicks Emerging Medical and Surgical Management Strategies in the Evaluation and Treatment of Intracerebral Hemorrhage Mayo Clin. Proc., March 1, 2005; 80(3): 420 - 433. [Abstract] [PDF]
|
|
|
|
 |
|
 C. L. O'Brien and B. F. Gage Costs and Effectiveness of Ximelagatran for Stroke Prophylaxis in Chronic Atrial Fibrillation JAMA, February 9, 2005; 293(6): 699 - 706. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. B. Matchar and A. G. Rudd Health Policy and Outcomes Research 2004 Stroke, February 1, 2005; 36(2): 225 - 227. [Full Text] [PDF]
|
|
|
|
|
|
W. D. Freeman, T. G. Brott, K. M. Barrett, P. R. Castillo, H. G. Deen Jr, L. F. Czervionke, and J. F. Meschia Recombinant Factor VIIa for Rapid Reversal of Warfarin Anticoagulation in Acute Intracranial Hemorrhage Mayo Clin. Proc., December 1, 2004; 79(12): 1495 - 1500. [Abstract] [PDF]
|
|
|
|
 |
|
 J P Hanley Warfarin reversal J. Clin. Pathol., November 1, 2004; 57(11): 1132 - 1139. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R Fuller, N J Dudley, J Maule, and T Stewart Dilemmas in managing intracerebral haemorrhage and thromboembolism J R Soc Med, June 1, 2004; 97(6): 308 - 309. [Full Text] [PDF]
|
|
|
|
|
|
S. M. Greenberg, J. A. Eng, M. Ning, E. E. Smith, and J. Rosand Hemorrhage Burden Predicts Recurrent Intracerebral Hemorrhage After Lobar Hemorrhage Stroke, June 1, 2004; 35(6): 1415 - 1420. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Rosand, M. H. Eckman, K. A. Knudsen, D. E. Singer, and S. M. Greenberg The Effect of Warfarin and Intensity of Anticoagulation on Outcome of Intracerebral Hemorrhage Arch Intern Med, April 26, 2004; 164(8): 880 - 884. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Butler, R. C. Tait, M. H. Eckman, D. E. Singer, J. Rosand, K. A. Knudsen, and S. M. Greenberg Restarting Oral Anticoagulation After Intracranial Hemorrhage * Response Stroke, January 1, 2004; 35 (1): e5 - e6. [Full Text] [PDF]
|
|
|
|
|
|
C. Stollberger, J. Finsterer, M. H. Eckman, J. Rosand, K. A. Knudsen, S. M. Greenberg, and D. E. Singer Antithrombotic Therapy After Cerebral Hemorrhages * Response Stroke, November 1, 2003; 34 (11): e217 - e218. [Full Text] [PDF]
|
|
|
|
 |
|
 Anticoagulation for Atrial Fibrillation After ICH: A Catch-22 Journal Watch Neurology, September 5, 2003; 2003(905): 2 - 2. [Full Text]
|
|